여에스더, "성형설? 칼 안댔다"...56세 때 ‘이것’ 후 광대뼈 들어가
가정의학과 전문의 겸 사업가 여에스더(59)가 성형설을 해명했다.
2일 방송된 KBS 2TV ‘박원숙의 같이 삽시다’에서 박원숙, 혜은이는 제주도에 있는 홍혜걸, 여에스더 부부의 집을 방문했다.…
카테고리 찾아보기
Bio-Pharm
Curocell Submits Korean Approval Application for ‘Rimcarto’
Curocell announced on the 30th that it has submitted a marketing authorization application to the Ministry of Food…
SK Bioscience and Sanofi Partner to Develop Next-Generation Pneumococcal Vaccine
SK Bioscience is teaming up with global pharmaceutical company Sanofi to jointly develop a next-generation pneumococcal…
Samsung Life Science Fund Invests in U.S. Biotech ‘Generate Biomedicines’
Samsung announced on the 18th that it has invested in the U.S.-based biotech company Generate Biomedicines through its…
Celltrion Launches CDMO Subsidiary ‘BioSolutions’
Celltrion has established a new subsidiary specializing in contract development and manufacturing organization…
FDA Approves Liga-Chem Bio’s IND for Novel ADC Cancer Therapy
Liga-Chem BioSciences announced that it has received approval from the U.S. Food and Drug Administration (FDA) for…
Cenobamate Proven Effective for Patients in Korea, China, and Japan
SK Biopharmaceuticals announced that its anti-epileptic drug Cenobamate has demonstrated clinical efficacy for…
Alteogen Receives USD 20 Million Upfront Payment from Daiichi Sankyo
Alteogen announced that it has received an upfront payment of USD 20 million (approximately KRW 28 billion) from…
Samsung Bioepis Appoints Kim Kyung-ah as New CEO After 13 Years
Samsung Bioepis announced a leadership change for the first time in 13 years.
On the 27th, the company announced that…
Daewoong "Ursa Shows Liver Function Improvement in Phase 4 Trial"
Ursa has once again proven its liver function improvement effects through clinical trials.
Daewoong Pharmaceutical…
Celltrion Secures First Approval for Prolia Biosimilar in Korea
Celltrion has received its first approval for a biosimilar of Prolia (denosumab), a treatment for osteoporosis.
On…
Samsung Biologics Breaks 5 Trillion KRW in Annual Orders for the First Time
Samsung Biologics has surpassed 5 trillion KRW in annual cumulative orders for the first time since its establishment.…
FDA Approved VUNO’s AI Chest X-ray Diagnostic Device
Medical AI company VUNO announced on the 19th that its AI-based chest X-ray diagnostic device, VUNO Med-Chest X-ray…
Lunit Partners with AstraZeneca to Develop ‘AI Pathology Solution’
Lunit, a medical AI company, announced on the 18th that it has signed a strategic collaboration agreement with…
Celltrion Acquires Swiss Pharmaceutical Distributor, iQone Healthcare Switzerland
Celltrion announced on the 15th that it has acquired the Swiss pharmaceutical distribution company "iQone Healthcare…
Global Pharma Companies Lining Up at Alteogen's Door – Why?
"By the 2030s, I envision Alteogen joining the ranks of companies with annual revenue in the trillions of won. We’ll…
Hugel Successfully Concludes HA Filler workshop for French medical experts
Hugel Inc., a leading global medical aesthetics company, said on Wednesday it had recently launched H.E.L.F. Global…
Alteogen Signs USD 280 Million Licensing Agreement with Daiichi Sankyo
Alteogen is advancing in the development of the world’s first subcutaneous (SC) injection for antibody-drug…
Hugel Sees Record Q3 Revenue and Profit with Botulax Growth
For the first time since its founding, Hugel has exceeded 100 billion KRW in quarterly revenue and 50 billion KRW in…
Huons Acquires PanGen... “Expanding CDMO Services for Biopharmaceuticals”
Huons is set to expand its biopharmaceutical R&D and contract development and manufacturing organization (CDMO)…